CA602 antigen

Known as: CA602 
 

Topic mentions per year

Topic mentions per year

1990-2005
01219902005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two… (More)
Is this relevant?
2005
2005
BACKGROUND It has been reported that prognosis is less favorable in poorly (G3) differentiated endometrioid adenocarcinoma than… (More)
Is this relevant?
1998
1998
In this study clinical studies were conducted on galactosyltransferase associated with tumour (GAT) as a newly developed marker… (More)
Is this relevant?
1997
1997
Changes in CA602 and CA546, two carbohydrate-related antigens newly established in our institute, were evaluated during the… (More)
  • figure 2
  • figure 3
  • table I
Is this relevant?
Review
1996
Review
1996
Several new trials, using tumor markers in the screening for gynecological malignancies, have been conducted. For assisting the… (More)
Is this relevant?
1994
1994
Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and… (More)
Is this relevant?
1993
1993
Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of… (More)
Is this relevant?
1992
1992
An immunoenzymometric assay (IEMA) for a new CA125-like antigen, CA602, was developed. Five monoclonal antibodies raised against… (More)
Is this relevant?
1991
1991
A cell line designated RMG-II was established from the ascites of a patient with ovarian clear cell carcinoma. The chromosomal… (More)
Is this relevant?
1990
1990
We investigated the usefulness of CA602, a newly developed serum tumor marker, for ovarian cancer. When the cut-off value was set… (More)
Is this relevant?